Stem Cell Therapy Market Size, Share, Analysis, Trends, Growth, Forecasts, 2032

Stem Cell Therapy Market

Stem Cell Therapy Market- By Cell Source (Adipose Tissue-Derived Mesenchymal SCs, Bone Marrow-Derived Mesenchymal SCs, and Embryonic SCs), By Type (Allogenic SCs And Autologous SCs), By End-User (ASCs And Hospitals), And By Therapeutic Application (Musculoskeletal Disorders, Wounds & Injuries, Cardiovascular Diseases, Gastrointestinal Diseases, and Immune System Diseases): Global Industry Perspective, Comprehensive Analysis, And Forecast, 2024-2032-

Category: Healthcare Report Format : PDF Pages: 110 Report Code: ZMR-2341 Published Date: Nov-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 275.38 Million USD 663.82 Million 10.27% 2023

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodulogy
      • 1.3.1. Market Research Type
      • 1.3.2. Market Research Methodulogy
  • Chapter 2. Executive Summary
    • 2.1. Stem Cell Therapy Market, 2018–2028(USD Million)
    • 2.2. Stem Cell Therapy Market: Snapshot
  • Chapter 3. Global Stem Cell Therapy Market– Industry Analysis
    • 3.1. Stem Cell Therapy Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Humungous utilization of stem cell therapy in treating metabulic disorders, eye ailments, musculoskeletal diseases, heart disorders, and central nervous system issues will prop up market size.
      • 3.2.2. Surge in government & private funding of research works associated with stem cell treatment projects will pruliferate industry expansion.
    • 3.3. Porter’s Five Forces Analysis
    • 3.4. Market Attractiveness Analysis
      • 3.4.1. Market attractiveness analysis By Therapeutic Application
      • 3.4.2. Market attractiveness analysis By Type
      • 3.4.3. Market attractiveness analysis By Cell Source
      • 3.4.4. Market attractiveness analysis By End-User
  • Chapter 4. Global Stem Cell Therapy Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Stem Cell Therapy Market: company market share, 2019
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Product launches
      • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Stem Cell Therapy Market– Cell Source Analysis
    • 5.1. Global Stem Cell Therapy Market overview: By Cell Source
      • 5.1.1. Global Stem Cell Therapy Market share, By Cell Source, 2020 and 2028
    • 5.2. Adipose Tissue-Derived Mesenchymal SCs
      • 5.2.1. Global Stem Cell Therapy Marketby Adipose Tissue-Derived Mesenchymal SCs, 2018–2028(USD Million)
    • 5.3. Bone Marrow-Derived Mesenchymal SCs
      • 5.3.1. Global Stem Cell Therapy Marketby Bone Marrow-Derived Mesenchymal SCs, 2018–2028(USD Million)
    • 5.4. Embryonic SCs
      • 5.4.1. Global Stem Cell Therapy Marketby Embryonic SCs, 2018–2028(USD Million)
  • Chapter 6. Global Stem Cell Therapy Marketoverview: By Type
    • 6.1. Global Stem Cell Therapy Marketshare, By Type , 2020 and 2028
    • 6.2. Allogenic SCs
      • 6.2.1. Global Stem Cell Therapy Marketby Allogenic SCs, 2018–2028(USD Million)
    • 6.3. Autulogous SCs
      • 6.3.1. Global Stem Cell Therapy Marketby Autulogous SCs, 2018–2028(USD Million)
  • Chapter 7. Global Stem Cell Therapy Marketoverview: By End-User
    • 7.1. Global Stem Cell Therapy Marketshare, By End-User , 2020 and 2028
    • 7.2. ASCs
      • 7.2.1. Global Stem Cell Therapy Marketby ASCs, 2018–2028(USD Million)
    • 7.3. Hospitals
      • 7.3.1. Global Stem Cell Therapy Marketby Hospitals, 2018–2028(USD Million)
  • Chapter 8. Global Stem Cell Therapy Marketoverview: By Therapeutic Application
    • 8.1. Global Stem Cell Therapy Marketshare, By Therapeutic Application , 2020 and 2028
    • 8.2. Musculoskeletal Disorders
      • 8.2.1. Global Stem Cell Therapy Marketby Musculoskeletal Disorders, 2018–2028(USD Million)
    • 8.3. Wounds & Injuries
      • 8.3.1. Global Stem Cell Therapy Marketby Wounds & Injuries, 2018–2028(USD Million)
    • 8.4. Cardiovascular Diseases
      • 8.4.1. Global Stem Cell Therapy Marketby Cardiovascular Diseases, 2018–2028(USD Million)
    • 8.5. Gastrointestinal Diseases
      • 8.5.1. Global Stem Cell Therapy Marketby Gastrointestinal Diseases, 2018–2028(USD Million)
    • 8.6. Immune System Diseases
      • 8.6.1. Global Stem Cell Therapy Marketby Immune System Diseases, 2018–2028(USD Million)
  • Chapter 9. Company Profiles
    • 9.1. MEDIPOST Co., Ltd.
      • 9.1.1. Overview
      • 9.1.2. Financials
      • 9.1.3. Product Portfulio
      • 9.1.4. Business Strategy
      • 9.1.5. Recent Developments
    • 9.2. JCR Pharmaceuticals Co., Ltd.
      • 9.2.1. Overview
      • 9.2.2. Financials
      • 9.2.3. Product Portfulio
      • 9.2.4. Business Strategy
      • 9.2.5. Recent Developments
    • 9.3. Anterogen Co., Ltd.
      • 9.3.1. Overview
      • 9.3.2. Financials
      • 9.3.3. Product Portfulio
      • 9.3.4. Business Strategy
      • 9.3.5. Recent Development
    • 9.4. NuVasive, Inc.
      • 9.4.1. Overview
      • 9.4.2. Financials
      • 9.4.3. Product Portfulio
      • 9.4.4. Business Strategy
      • 9.4.5. Recent Development
    • 9.5. RTI Surgical, Inc.
      • 9.5.1. Overview
      • 9.5.2. Financials
      • 9.5.3. Product Portfulio
      • 9.5.4. Business Strategy
      • 9.5.5. Recent Development
    • 9.6. Pharmicell Co., Ltd.
      • 9.6.1. Overview
      • 9.6.2. Financials
      • 9.6.3. Product Portfulio
      • 9.6.4. Business Strategy
      • 9.6.5. Recent Development
    • 9.7. Hulostem Terapie Avanzate S.r.l.
      • 9.7.1. Overview
      • 9.7.2. Financials
      • 9.7.3. Product Portfulio
      • 9.7.4. Business Strategy
      • 9.7.5. Recent Development
    • 9.8. AlloSource
      • 9.8.1. Overview
      • 9.8.2. Financials
      • 9.8.3. Product Portfulio
      • 9.8.4. Business Strategy
      • 9.8.5. Recent Development

Table Of Figures

List of Figures

1. Market research Type
2. Market research methodology
3. Global Stem Cell Therapy Market, 2018–2028(USD Million)
4. Porter’s Five Forces Analysis
5. Global Stem Cell Therapy Marketattractiveness, By Therapeutic Application
6. Global Stem Cell Therapy Marketattractiveness, By Type
7. Global Stem Cell Therapy Marketattractiveness, By Cell Source
8. Global Stem Cell Therapy Marketattractiveness, By End-User
9. Global Stem Cell Therapy Marketshare by Cell Source ,2020 and 2028 (USD Million)
10. Global Stem Cell Therapy Marketby Adipose Tissue-Derived Mesenchymal SCs, 2018–2028(USD Million)
11. Global Stem Cell Therapy Marketby Bone Marrow-Derived Mesenchymal SCs, 2018–2028(USD Million)
12. Global Stem Cell Therapy Marketby Embryonic SCs, 2018–2028(USD Million)
13. Global Stem Cell Therapy Marketshare by Type ,2020 and 2028 (USD Million)
14. Global Stem Cell Therapy Marketby Allogenic SCs, 2018–2028(USD Million)
15. Global Stem Cell Therapy Marketby Autologous SCs, 2018–2028(USD Million)
16. Global Stem Cell Therapy Marketshare by Therapeutic Application ,2020 and 2028 (USD Million)
17. Global Stem Cell Therapy Marketby Musculoskeletal Disorders, 2018–2028(USD Million)
18. Global Stem Cell Therapy Marketby Wounds & Injuries, 2018–2028(USD Million)
19. Global Stem Cell Therapy Marketby Cardiovascular Diseases, 2018–2028(USD Million)
20. Global Stem Cell Therapy Marketby Gastrointestinal Diseases, 2018–2028(USD Million)
21. Global Stem Cell Therapy Marketby Immune System Diseases, 2018–2028(USD Million)
22. Global Stem Cell Therapy Marketshare by End-User ,2020 and 2028 (USD Million)
23. Global Stem Cell Therapy Marketby ASCS, 2018–2028(USD Million)
24. Global Stem Cell Therapy Marketby Hospitals,  2018–2028(USD Million)
25. Global Stem Cell Therapy Marketshare, by Region, 2020 and 2028
26. North America Stem Cell Therapy Market, 2018–2028(USD Million)
27. Europe Stem Cell Therapy Market, 2018–2028(USD Million)
28. Asia Pacific Stem Cell Therapy Market, 2018–2028(USD Million)
29. Latin America Stem Cell Therapy Market, 2018–2028(USD Million)
30. The Middle East and Africa Stem Cell Therapy Market, 2018–2028(USD Million)


Table Of Tables

List of Tables

1. Global Stem Cell Therapy Market: snapshot
2. Drivers of the Stem Cell Therapy Market: impact analysis
3. North America Stem Cell Therapy Marketrevenue, By Therapeutic Application  ,2018–2028(USD Million)
4. North America Stem Cell Therapy Marketrevenue, By Type ,2018–2028(USD Million)
5. North America Stem Cell Therapy Marketrevenue, By Cell Source ,2018–2028(USD Million)
6. North America Stem Cell Therapy Marketrevenue, By End-User ,2018–2028(USD Million)
7. The U.S. Stem Cell Therapy Marketrevenue, By Therapeutic Application  ,2018–2028(USD Million)
8. The U.S. Stem Cell Therapy Marketrevenue, By Type ,2018–2028(USD Million)
9. The U.S. Stem Cell Therapy Marketrevenue, By Cell Source ,2018–2028(USD Million)
10. The U.S. Stem Cell Therapy Marketrevenue, By End-User ,2018–2028(USD Million)
11. Rest of North America Stem Cell Therapy Marketrevenue, By Therapeutic Application  ,2018–2028(USD Million)
12. Rest of North America Stem Cell Therapy Marketrevenue, By Type ,2018–2028(USD Million)
13. Rest of North America Stem Cell Therapy Marketrevenue, By Cell Source ,2018–2028(USD Million)
14. Rest of North America Stem Cell Therapy Marketrevenue, By End-User ,2018–2028(USD Million)
15. Europe Stem Cell Therapy Marketrevenue, By Therapeutic Application  ,2018–2028(USD Million)
16. Europe Stem Cell Therapy Marketrevenue, By Type ,2018–2028(USD Million)
17. Europe Stem Cell Therapy Marketrevenue, By Cell Source ,2018–2028(USD Million)
18. Europe Stem Cell Therapy Marketrevenue, By End-User ,2018–2028(USD Million)
19. UK Stem Cell Therapy Marketrevenue, By Therapeutic Application  ,2018–2028(USD Million)
20. UK Stem Cell Therapy Marketrevenue, By Type ,2018–2028(USD Million)
21. UK Stem Cell Therapy Marketrevenue, By Cell Source ,2018–2028(USD Million)
22. UK Stem Cell Therapy Marketrevenue, By End-User ,2018–2028(USD Million)
23. France Stem Cell Therapy Marketrevenue, By Therapeutic Application  ,2018–2028(USD Million)
24. France Stem Cell Therapy Marketrevenue, By Type ,2018–2028(USD Million)
25. France Stem Cell Therapy Marketrevenue, By Cell Source ,2018–2028(USD Million)
26. France Stem Cell Therapy Marketrevenue, By End-User ,2018–2028(USD Million)
27. Germany Stem Cell Therapy Marketrevenue, By Therapeutic Application  ,2018–2028(USD Million)
28. Germany Stem Cell Therapy Marketrevenue, By Type ,2018–2028(USD Million)
29. Germany Stem Cell Therapy Marketrevenue, By Cell Source ,2018–2028(USD Million)
30. Germany Stem Cell Therapy Marketrevenue, By End-User ,2018–2028(USD Million)
31. Rest of Europe Stem Cell Therapy Marketrevenue, By Therapeutic Application  ,2018–2028(USD Million)
32. Rest of Europe Stem Cell Therapy Marketrevenue, By Type ,2018–2028(USD Million)
33. Rest of Europe Stem Cell Therapy Marketrevenue, By Cell Source ,2018–2028(USD Million)
34. Rest of Europe Stem Cell Therapy Marketrevenue, By End-User ,2018–2028(USD Million)
35. Asia Pacific Stem Cell Therapy Marketrevenue, By Therapeutic Application  ,2018–2028(USD Million)
36. Asia Pacific Stem Cell Therapy Marketrevenue, By Type ,2018–2028(USD Million)
37. Asia Pacific Stem Cell Therapy Marketrevenue, By Cell Source ,2018–2028(USD Million)
38. Asia Pacific Stem Cell Therapy Marketrevenue, By End-User ,2018–2028(USD Million)
39. China Stem Cell Therapy Marketrevenue, By Therapeutic Application  ,2018–2028(USD Million)
40. China Stem Cell Therapy Marketrevenue, By Type ,2018–2028(USD Million)
41. China Stem Cell Therapy Marketrevenue, By Cell Source ,2018–2028(USD Million)
42. China Stem Cell Therapy Marketrevenue, By End-User ,2018–2028(USD Million)
43. Japan Stem Cell Therapy Marketrevenue, By Therapeutic Application  ,2018–2028(USD Million)
44. Japan Stem Cell Therapy Marketrevenue, By Type ,2018–2028(USD Million)
45. Japan Stem Cell Therapy Marketrevenue, By Cell Source ,2018–2028(USD Million)
46. Japan Stem Cell Therapy Marketrevenue, By End-User ,2018–2028(USD Million)
47. India Stem Cell Therapy Marketrevenue, By Therapeutic Application  ,2018–2028(USD Million)
48. India Stem Cell Therapy Marketrevenue, By Type ,2018–2028(USD Million)
49. India Stem Cell Therapy Marketrevenue, By Cell Source ,2018–2028(USD Million)
50. India Stem Cell Therapy Marketrevenue, By End-User ,2018–2028(USD Million)
51. Rest of Asia Pacific Stem Cell Therapy Marketrevenue, By Therapeutic Application  ,2018–2028(USD Million)
52. Rest of Asia Pacific Stem Cell Therapy Marketrevenue, By Type ,2018–2028(USD Million)
53. Rest of Asia Pacific Stem Cell Therapy Marketrevenue, By Cell Source ,2018–2028(USD Million)
54. Rest of Asia Pacific Stem Cell Therapy Marketrevenue, By End-User ,2018–2028(USD Million)
55. Latin America Stem Cell Therapy Marketrevenue, By Therapeutic Application  ,2018–2028(USD Million)
56. Latin America Stem Cell Therapy Marketrevenue, By Type ,2018–2028(USD Million)
57. Latin America Stem Cell Therapy Marketrevenue, By Cell Source ,2018–2028(USD Million)
58. Latin America Stem Cell Therapy Marketrevenue, By End-User ,2018–2028(USD Million)
59. Brazil Stem Cell Therapy Marketrevenue, By Therapeutic Application  ,2018–2028(USD Million)
60. Brazil Stem Cell Therapy Marketrevenue, By Type ,2018–2028(USD Million)
61. Brazil Stem Cell Therapy Marketrevenue, By Cell Source ,2018–2028(USD Million)
62. Brazil Stem Cell Therapy Marketrevenue, By End-User ,2018–2028(USD Million)
63. Rest of Latin America Stem Cell Therapy Marketrevenue, By Therapeutic Application  ,2018–2028(USD Million)
64. Rest of Latin  America Stem Cell Therapy Marketrevenue, By Type ,2018–2028(USD Million)
65. Rest of Latin America Stem Cell Therapy Marketrevenue, By Cell Source ,2018–2028(USD Million)
66. Rest of Latin America Stem Cell Therapy Marketrevenue, By End-User ,2018–2028(USD Million)
67. The Middle East and Africa Stem Cell Therapy Marketrevenue, By Therapeutic Application  ,2018–2028(USD Million)
68. The Middle East and Africa Stem Cell Therapy Marketrevenue, By Type ,2018–2028(USD Million)
69. The Middle East and Africa Stem Cell Therapy Marketrevenue, By Cell Source ,2018–2028(USD Million)
70. The Middle East and Africa Stem Cell Therapy Marketrevenue, By End-User ,2018–2028(USD Million)
71. Saudi Arabia Stem Cell Therapy Marketrevenue, By Therapeutic Application  ,2018–2028(USD Million)
72. Saudi Arabia Stem Cell Therapy Marketrevenue, By Type ,2018–2028(USD Million)
73. Saudi Arabia Stem Cell Therapy Marketrevenue, By Cell Source ,2018–2028(USD Million)
74. Saudi Arabia Stem Cell Therapy Marketrevenue, By End-User ,2018–2028(USD Million)
75. South Africa Stem Cell Therapy Marketrevenue, By Therapeutic Application  ,2018–2028(USD Million)
76. South Africa Stem Cell Therapy Marketrevenue, By Type ,2018–2028(USD Million)
77. South Africa Stem Cell Therapy Marketrevenue, By Cell Source ,2018–2028(USD Million)
78. South Africa Stem Cell Therapy Marketrevenue, By End-User ,2018–2028(USD Million)
79. Rest of the Middle East & Africa Stem Cell Therapy Marketrevenue, By Therapeutic Application  ,2018–2028(USD Million)
80. Rest of the Middle East & Africa Stem Cell Therapy Marketrevenue, By Type ,2018–2028(USD Million)
81. Rest of the Middle East & Africa Stem Cell Therapy Marketrevenue, By Cell Source ,2018–2028(USD Million)
82. Rest of the Middle East & Africa Stem Cell Therapy Marketrevenue, By End-User ,2018–2028(USD Million)


 

Methodology

FrequentlyAsked Questions

Preclinical and medical research activities have brought enormous improvements in stem cell treatments and the latter is a best option having high potential for treating various kinds of diseases in which current medical therapies have failed to cure, prevent disease development, and alleviate disease symptoms. This aspect is likely to offer new growth opportunities for stem cell therapy market.

According to Zion market research report, The global Stem Cell Therapy Market, estimating its value at USD 275.38 Million in 2023, with projections indicating that it will reach USD 663.82 Million by 2032. The market is expected to expand at a compound annual growth rate (CAGR) of 10.27% over the forecast period 2024-2032. 

North America will contribute lucratively towards the global market earnings over the projected timeline. The regional market surge is subject to rise in clinical research pertaining to stem cell therapy in countries such as the U.S. In addition to this, rise in chronic diseases and government aid facilitating use of stem cell treatment for these severe disorders will enlarge scope of market in region. Apart from this, thriving biotechnology sector and massive research in whole genome synthesis domain and genome sequencing field will protrude expansion of stem cell therapy market in sub-continent.

The key market participants include MEDIPOST Co., Ltd., JCR Pharmaceuticals Co., Ltd., Anterogen Co., Ltd., NuVasive, Inc., RTI Surgical, Inc., Pharmicell Co., Ltd., Holostem Terapie Avanzate S.r.l., and AlloSource. 

 

Choose License Type

  • zion payment modes

List of Contents

Stem Cell Therapy Market InsightsStem Cell Therapy OutlookStem Cell Therapy Growth DriversStem Cell Therapy Regional LandscapeStem Cell Therapy Report ScopeStem Cell Therapy Competitive LandscapeThe global Stem Cell Therapy Market is segmented as follows:By Cell SourceBy TypeBy End-User By Therapeutic Application By Region

RelatedNews

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

How it Works?

Our Company

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed